CWGCX
Price
$64.17
Change
+$0.19 (+0.30%)
Updated
May 8 closing price
Net Assets
124.56B
RGLAX
Price
$24.30
Change
+$0.03 (+0.12%)
Updated
May 8 closing price
Net Assets
15.86B
Ad is loading...

CWGCX vs RGLAX

Header iconCWGCX vs RGLAX Comparison
Open Charts CWGCX vs RGLAXBanner chart's image
American Funds Capital World Gr&Inc C
Price$64.17
Change+$0.19 (+0.30%)
VolumeN/A
Net Assets124.56B
American Funds Global Insight R-1
Price$24.30
Change+$0.03 (+0.12%)
VolumeN/A
Net Assets15.86B
CWGCX vs RGLAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. RGLAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and RGLAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 125B vs. RGLAX (15.9B). CWGCX pays higher dividends than RGLAX: CWGCX (0.92) vs RGLAX (0.31). CWGCX was incepted earlier than RGLAX: CWGCX (24 years) vs RGLAX (6 years). RGLAX (1.52) and CWGCX (1.49) have similar cost to investors . CWGCX is a more actively managed with annual turnover of: 27.00 vs. RGLAX (21.00). CWGCX (250) and RGLAX (250) have matching initial minimum investment requirements. RGLAX annual gain was more profitable for investors over the last year : 7.99 vs. CWGCX (1.49). RGLAX return over 5 years is better than : 61.73 vs. CWGCX (47.06).
CWGCXRGLAXCWGCX / RGLAX
Total Expense Ratio1.491.5298%
Annual Report Gross Expense Ratio1.491.5298%
Fund Existence24 years6 years-
Gain YTD2.4074.02460%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets125B15.9B786%
Annual Yield % from dividends0.920.31302%
Returns for 1 year1.497.9919%
Returns for 3 years28.5836.7978%
Returns for 5 years47.0661.7376%
Returns for 10 years37.47N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CNCR9.120.27
+3.05%
Range Cancer Therapeutics ETF
JVAL41.010.48
+1.19%
JPMorgan US Value Factor ETF
GDV23.980.10
+0.42%
Gabelli Dividend & Income Trust (The)
BRLN51.40N/A
N/A
iShares Floating Rate Loan Active ETF
PHYD50.96-0.02
-0.03%
Putnam ESG High Yield ETF